Market Overview

Bioamber (NYSE: )

0.00 0.00 (0.00%)

Earnings

QuarterPriorEstimateActualSurprise
Q4 2017
After-Hours
EPS:
REV:
-0.27
631K

3.3M
-1.61
5.396M

63.52%
Q3 2017
After-Hours
EPS:
REV:
-0.26
3.661M

6.75M
-0.21
3.301M

-51.1%
Q2 2017
Pre-Market
EPS:
REV:
-0.25
2.521M
-0.13
4.43M
-0.20
4.122M
53.85%
-6.95%
Q1 2017
After-Hours
EPS:
REV:
-0.29
1.458M
-0.13
4.02M
-0.31
2.123M
138.46%
-47.19%
Q4 2016
After-Hours
EPS:
REV:
-0.36
1.111M
-0.18
3.78M
-0.27
631K
50%
-83.31%
Q3 2016
After-Hours
EPS:
REV:
-0.36
352K
-0.22
3.85M
-0.26
3.661M
-1818.18%
-490.91%
Q2 2016
After-Hours
EPS:
REV:
-0.39
342K
-0.27
2.37M
-0.25
2.521M

Q1 2016
After-Hours
EPS:
REV:
-0.39
367K
-0.24
2.17M
-0.29
1.458M

Q4 2015
After-Hours
EPS:
REV:
0.48
308K
-0.35
830K
-0.36
1.111M

Q3 2015
After-Hours
EPS:
REV:
-0.41
469K
-0.41
2.3M
-0.36
352K

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!